Steelhead Partners »

Halozyme Therapeutics shares owned by Steelhead Partners

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Steelhead Partners from 13F filings

Historical chart of Steelhead Partners investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Steelhead Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Steelhead Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $128B 112M 1147.77
2025-06-30 $65B 65M 995.85

More positions owned by Steelhead Partners

Halo 0 1/4 03/01/27 Note 0.250% 3/0 (Principal)
Itri 0 03/15/26 Note 3/1 (Principal)
Aeis 2 1/2 09/15/28 Note 2.500% 9/1 (Principal)
Uber 0 12/15/25 Note 12/1 (Principal)
BL 1 06/01/29 Note 1.000% 6/0 (Principal)
Alrm 2 1/4 06/01/29 Note 2.250% 6/0 (Principal)
Uber 0 7/8 12/01/28 Note 0.875%12/0 (Principal)
DXCM 0 3/8 05/15/28 Note 0.375% 5/1 (Principal)
Spot 0 03/15/26 Note 3/1 (Principal)
Sealtd 0 1/4 09/15/26 Note 0.250% 9/1 (Principal)
Box 0 01/15/26 Note 1/1 (Principal)
Akam 1 1/8 02/15/29 Note 1.125% 2/1 (Principal)
Akam 0 3/8 09/01/27 Note 0.375% 9/0 (Principal)
Net 0 08/15/26 Note 8/1 (Principal)
Jazz 2 06/15/26 Note 2.000% 6/1 (Principal)

View all positions for Steelhead Partners

Top funds holding Halozyme Therapeutics

Steelhead Partners
Opti Capital Management
Linden Advisors
Millennium Management
MacKay Shields
DeepCurrents Investment Group
Tenor Capital Management
BlackRock
Lazard Asset Management
M&G
Calamos Advisors
Wellesley Investment Advisors
UBS O'Connor
Jpmorgan Chase & Co
State Street Corporation

View all funds holding Halozyme Therapeutics